Jay E. Birnbaum
CIK: 0001397470
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SNOA
Sonoma Pharmaceuticals, Inc.
Director
Discretionary Trading P&L
Holdings
About Birnbaum Jay E
Birnbaum Jay E (SEC CIK 0001397470) files insider reports with the SEC as Director of Sonoma Pharmaceuticals, Inc. (SNOA).
Signal8 holds 2 ownership filings by Birnbaum Jay E, all Form 4s, filed between Jan 3, 2025 and Jan 2, 2026. Those filings report 2 transactions, from Jan 2, 2025 to Jan 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Birnbaum Jay E's filings is in BOULDER, CO.
Recent filings by Birnbaum Jay E
Other insiders filing for Sonoma Pharmaceuticals, Inc. (SNOA)
- Weigerstorfer Philippe, Director
- Trombly Amy Moss, Chief Executive Officer
- MCLAUGHLIN JOHN, Director
- Jacoby Vanessa, Director
- DVONCH JEROME J, Chief Financial Officer
- Dal Poggetto John, Controller